 | NASH: The Second Wave
seekingalpha.com - February 20 at 6:54 PM |
 | Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 16 at 11:03 AM |
| Brokerages Anticipate Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Will Post Quarterly Sales of $30.66 Million
www.americanbankingnews.com - February 14 at 3:42 AM |
| Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Expected to Post Q2 2020 Earnings of ($0.83) Per Share
www.americanbankingnews.com - February 13 at 9:20 AM |
| -$0.63 Earnings Per Share Expected for Enanta Pharmaceuticals Inc (NASDAQ:ENTA) This Quarter
www.americanbankingnews.com - February 12 at 4:27 AM |
 | Edited Transcript of ENTA earnings conference call or presentation 6-Feb-20 9:30pm GMT
finance.yahoo.com - February 10 at 2:26 PM |
| Enanta Pharmaceuticals (NASDAQ:ENTA) Releases Earnings Results
www.americanbankingnews.com - February 7 at 7:03 PM |
| Enanta Pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - February 6 at 10:43 PM |
 | Enanta Pharmaceuticals Inc (ENTA) Q1 2020 Earnings Call Transcript
www.fool.com - February 6 at 10:43 PM |
| Enanta Pharmaceuticals (ENTA) Q1 Earnings Top Estimates
finance.yahoo.com - February 6 at 10:43 PM |
| Enanta Pharma EPS beats by $0.09, misses on revenue
seekingalpha.com - February 6 at 5:43 PM |
| Enanta Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - February 6 at 5:43 PM |
| Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019
finance.yahoo.com - February 6 at 5:43 PM |
| Enanta Pharma Q1 2020 Earnings Preview
seekingalpha.com - February 5 at 7:31 PM |
| Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) High P/E Ratio A Problem For Investors?
finance.yahoo.com - February 3 at 8:51 AM |
| Oppenheimer Weighs in on Enanta Pharmaceuticals Inc's FY2020 Earnings (NASDAQ:ENTA)
www.americanbankingnews.com - February 3 at 6:59 AM |
| Brokers Offer Predictions for Enanta Pharmaceuticals Inc's Q1 2020 Earnings (NASDAQ:ENTA)
www.americanbankingnews.com - January 31 at 9:49 AM |
| Earnings Preview: Enanta Pharmaceuticals (ENTA) Q1 Earnings Expected to Decline
finance.yahoo.com - January 30 at 2:30 PM |
| Enanta Pharmaceuticals (ENTA) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - January 30 at 2:50 AM |
| Enanta to Host Conference Call on February 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2019
finance.yahoo.com - January 24 at 8:35 AM |
| Enanta Pharma (ENTA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 14 at 5:15 PM |
| AbbVie's MAVIRET® now listed on the Newfoundland and Labrador formulary
finance.yahoo.com - January 14 at 6:53 AM |
 | Enanta Pharmaceuticals Becomes Oversold (ENTA)
www.nasdaq.com - January 14 at 1:53 AM |
| Enanta to provide R&D and business update for 2020 during annual JPM conference
seekingalpha.com - January 9 at 2:18 PM |
| Enanta to Provide Updates on its R&D Programs and Business Outlook for 2020 during the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 9 at 2:18 PM |
| Does This Valuation Of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Imply Investors Are Overpaying?
finance.yahoo.com - January 4 at 1:54 PM |
| Enanta Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 30 at 3:56 PM |
| Is Enanta Pharmaceuticals Inc (ENTA) A Good Stock To Buy?
finance.yahoo.com - December 11 at 12:56 PM |
| Should You Worry About Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) CEO Pay Cheque?
finance.yahoo.com - December 9 at 12:18 PM |
| Edited Transcript of ENTA earnings conference call or presentation 21-Nov-19 9:30pm GMT
finance.yahoo.com - November 26 at 9:19 PM |
| Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales
www.nasdaq.com - November 22 at 6:18 AM |
| Enanta Pharmaceuticals Inc (ENTA) Q4 2019 Earnings Call Transcript
www.fool.com - November 21 at 10:08 PM |
| Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019
finance.yahoo.com - November 21 at 6:55 PM |
| Enanta Pharmaceuticals (ENTA) Lags Q4 Earnings and Revenue Estimates
finance.yahoo.com - November 21 at 6:55 PM |
| Enanta Pharmaceuticals, Inc. Common Stock (ENTA) Earnings Report Date
www.nasdaq.com - November 20 at 11:33 PM |
| Enanta Pharma Q3 2019 Earnings Preview
seekingalpha.com - November 20 at 6:31 PM |
| Commit To Buy Enanta Pharmaceuticals At $55, Earn 16.5% Annualized Using Options
www.nasdaq.com - November 20 at 1:31 PM |
| Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) 14% ROE Worse Than Average?
finance.yahoo.com - November 11 at 1:41 PM |
| Enanta Pharmaceuticals Announces Poster Presentations at The Liver Meeting® 2019
finance.yahoo.com - November 11 at 8:40 AM |
| Enanta Pharmaceuticals (ENTA) Presents At Wolfe Research Healthcare Conference - Slideshow
seekingalpha.com - November 7 at 10:18 PM |
| Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019
finance.yahoo.com - November 5 at 6:34 PM |
| Enanta Pharmaceuticals to Present at the 2019 Wolfe Research Healthcare Conference
finance.yahoo.com - October 21 at 6:06 PM |
| Is Enanta Pharmaceuticals's (NASDAQ:ENTA) Share Price Gain Of 145% Well Earned?
finance.yahoo.com - October 12 at 10:21 PM |
| Is Enanta Pharmaceuticals's (NASDAQ:ENTA) Share Price Gain Of 145% Well Earned?
finance.yahoo.com - October 12 at 12:19 PM |
| New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions (p<0.001) in Total Symptom Score, Mucus Weight and RSV Viral Load as Measured by RT-PCR Assay and by Plaque Assay
finance.yahoo.com - October 3 at 9:21 AM |
| Enanta's Stock Down Despite NASH Drug Meeting Goal in Study
finance.yahoo.com - September 27 at 9:26 PM |
 | 21 Healthcare Stocks Moving In Thursday's Pre-Market Session
www.msn.com - September 27 at 9:26 PM |
 | Is Enanta Pharma in Trouble Despite Positive Results?
247wallst.com - September 26 at 4:56 PM |
| Enanta Pharma NASH candidate successful in mid-stage study; shares up 1% after hours
seekingalpha.com - September 25 at 8:42 PM |
| Enanta Announces Positive Results of ARGON-1 Study of its lead FXR Agonist, EDP-305, for the Treatment of NASH
finance.yahoo.com - September 25 at 8:42 PM |
